BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
4611 results:

  • 1. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
    Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinical and Radiological Factors for Predicting Clinically Significant prostate cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions.
    Zhang Z; Hu C; Lin Y; Song O; Gong D; Zhang X; Wang N
    Technol Cancer Res Treat; 2024; 23():15330338241246636. PubMed ID: 38629205
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
    Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
    BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy.
    He Y; Fan Y; Song H; Shen Q; Ruan M; Chen Y; Li D; Li X; Liu Y; Zhang K; Zhang Q
    BMC Urol; 2024 Apr; 24(1):85. PubMed ID: 38614971
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Difference between prostate cancer patients' Gleason scores from preoperative biopsy and those from postoperative pathology].
    Zhao XD; Liu YH; Hu J; Wang ZH; Jin XX; Ma MF; Zhou YL; Chen YH; Cao J; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 May; 29(5):393-401. PubMed ID: 38602754
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Is Unilateral Lymphadenectomy an Option in Selected Patients with prostate cancer?
    Kassab BN; De Pablos-Rodríguez P; Ferrer ÁG; García AC; Fons AC; Aragón F; Ramón-Borja JC; Ramírez-Backhaus M
    Arch Esp Urol; 2024 Mar; 77(2):129-134. PubMed ID: 38583004
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogram.
    Cheng Y; Fan B; Fu Y; Yin H; Lu J; Li D; Li X; Qiu X; Guo H
    BMC Urol; 2024 Apr; 24(1):76. PubMed ID: 38566091
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
    Alrohaibani A; Osunkoya AO
    Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
    Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
    Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dietary and Smoking Acrylamide and prostate cancer Risk: CAPLIFE Study.
    Lozano-Lorca M; Muñoz-Bravo C; Barrios-Rodríguez R; Castillo-Hermoso MÁ; Kouiti M; González-Palacios Torres C; Jiménez-Moleón JJ; Olmedo-Requena R
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542747
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of extracellular vesicles from their Raman spectra via self-supervised learning.
    Jensen MN; Guerreiro EM; Enciso-Martinez A; Kruglik SG; Otto C; Snir O; Ricaud B; Hellesø OG
    Sci Rep; 2024 Mar; 14(1):6791. PubMed ID: 38514697
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world analysis of apalutamide-associated skin rash in Chinese patients with prostate cancer.
    Yang Z; Shao Y; Huang H; Liu Y; Wang Z; Wang Y
    World J Urol; 2024 Mar; 42(1):171. PubMed ID: 38506974
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Li ZM; Liang ZH; Liu N; Wei KR
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
    [No Abstract]    [Full Text] [Related]  

  • 14. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.
    Cui H; Zhang W; Zhang L; Qu Y; Xu Z; Tan Z; Yan P; Tang M; Yang C; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
    PLoS Med; 2024 Mar; 21(3):e1004362. PubMed ID: 38489391
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The impact of the relationship between lesion diameter and total core length on the detection rate of clinically significant prostate cancer for PI-RADS 3 lesions.
    Yakut E
    World J Urol; 2024 Mar; 42(1):162. PubMed ID: 38488892
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Value of next generation sequencing (NGS) testing in advanced cancer patients.
    Ortendahl JD; Cuyun Carter G; Thakkar SG; Bognar K; Hall DW; Abdou Y
    J Med Econ; 2024; 27(1):519-530. PubMed ID: 38466204
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict prostate cancer Risk.
    Patel HD; Remmers S; Ellis JL; Li EV; Roobol MJ; Fang AM; Davik P; Rais-Bahrami S; Murphy AB; Ross AE; Gupta GN
    JAMA Netw Open; 2024 Mar; 7(3):e241516. PubMed ID: 38451522
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [
    Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
    Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic value of
    Guo S; Zhou C; Zhang Y; Wang D; Niu T; Zhou F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1812-1819. PubMed ID: 38448374
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effect of health belief model-based educational intervention on prostate cancer prevention; knowledge, practices, and intentions.
    Khalil MIM; Ashour A; Shaala RS; Allam RM; Abdelaziz TM; Mousa EFS
    BMC Cancer; 2024 Mar; 24(1):289. PubMed ID: 38438952
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 231.